SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

LYKA LABS

BSE: 500259 12 Jul 2025
Healthcare
₹ 109.9
Lyka Labs Ltd., specializes in Pharmaceuticals within the Healthcare sector.

LYKA LABS - Share Price & Details

Market Cap
₹393.0
High /Low
177.0 / 90.2
Stock P/E
49.7
Book Value
₹29.0
Dividend Yield
0.0
ROCE
9.91
ROE
₹9.21
Face Value
10.0
PEG Ratio
2.78
EVEBITDA
₹21.4
Debt
39.2
CMP / FCF
-449.0
Debt to equity
₹0.38
NP Ann
7.93
High price all time
267.0
Piotroski score
₹5.0
Graham Number
38.3
No. Eq. Shares
3.57
Net CF
₹-4.60
Net profit
7.93
Price to book value
3.8
Interest Coverage
₹5.89
Low price all time
8.15
Industry PE
33.5
Reserves
₹67.9
Free Cash Flow
₹-10.4

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4891.3
Triochem Products Ltd.,3.25-4.52NA-18.440
LYKA LABS LTD.342.4920.29334.290.49393.049.7
EVEREST ORGANICS LTD.411.5129.13409.351.35391
ZENOTECH LABORATORIES LTD.126.2412.30111.130.0037483.2

Peer Comparison Chart


About LYKA LABS

Lyka Labs Ltd.,, with Security Code 500259, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Lyka Labs Full Year 2025 Earnings: EPS: ₹2.22 (vs ₹0.79 loss in FY 2024)

(11 Jul 2025)
Lyka Labs ( NSE:LYKALABS ) Full Year 2025 Results Key Financial Results Revenue: ₹1.35b (up 27% from FY 2024). Net...
Read more →

Is Lyka Labs overvalued or undervalued?

(18 Jun 2025)
As of June 13, 2025, Lyka Labs is fairly valued with a PE ratio of 49.91, an EV to EBITDA of 25.12, and a PEG ratio of 0.11, though it remains more...
Read more →

What does Lyka Labs do?

(09 Jun 2025)
Lyka Labs Ltd is a micro-cap company in the Pharmaceuticals & Biotechnology sector, focusing on manufacturing formulations, bulk drugs, and healthcare...
Read more →

How has been the historical performance of the Lyka Labs?

(07 Jun 2025)
Lyka Labs has shown fluctuating financial performance, with net sales increasing from Rs 93.07 crore in March 2023 to Rs 138.50 crore in...
Read more →

Lyka Labs Experiences Valuation Grade Change Amidst Competitive Industry Landscape

(06 Jun 2025)
Lyka Labs, a microcap in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation, with its current price at 115.80. Over the past year,...
Read more →

Lyka Labs Adjusts Valuation Amid Rising Debt Concerns and Market Position Changes

(04 Jun 2025)
Lyka Labs, a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a score adjustment reflecting changes in its financial...
Read more →

Company Updates